Berberine Sulfate 133 mg*
For clients not seeking weight loss, we offer a GLP-1 micro-dosing option designed to support overall metabolic health, appetite regulation, inflammation control, and blood sugar stability
Conclusions Although studies have demonstrated the efficacy of GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors in improving conditions associated with new-onset diabetes mellitus (DM) and chronic kidney disease (CKD), there is a scarcity of data regarding their use after liver transplantation
Outcome timelines vary by protocol, adherence, and clinician adjustments, and are shown here only as directional prototype content for review
Sublingual GLP-1 Drops: Whats Really Going On What Are Semaglutide Drops
International Society of Sports Nutrition